The UofL Center for Cancer Immunology & Immunotherapy (CCII) is a pioneering NIH-supported program with a clear mission: to cultivate a robust community of investigators and advanced biomedical research infrastructure focused on cancer immunology and immunotherapy. As a leading research institution, UofL actively engages in the NIH IDeA program, demonstrating its commitment to fostering scientific excellence and innovation. Since its founding, CCII has played a pivotal role in spearheading over 15 research projects, encompassing both Research Projects and Pilot Projects. This demonstrates UofL's dedication to driving forward impactful discoveries and advancements in the critical fields of cancer immunology and immunotherapy.